Running Title: Genetic and environmental correlations of breast density and sex hormones.
INTRODUCTION
Higher circulating estradiol (E2) and testosterone (T) levels are known to increase the risk of postmenopausal breast cancer, while risk is inversely related to levels of sex hormonebinding globulin (SHBG), which binds estradiol and testosterone with high affinity, effectively limiting their bioavailability (1) (2) (3) . It has been hypothesized that the hormone levels affect risk mainly through their proliferative effects on mammary tissue (2, 4) , This proliferative activity may lead to not only greater areas of fibroglandular tissue at risk of developing cancer but also to a higher risk of mutations, as higher mitotic rates increases susceptibility to mutations (5) . Fibroglandular tissues within breasts are radio-dense and appear lighter than fat on a mammogram and this dense area is referred to as mammographic density. Women with dense tissue in more than 75% of their breasts are known to be at [4] [5] [6] fold increased risk of breast cancer relative to women with <10% dense tissue, after taking into account other known risk factors for the disease (6) . Most studies to date have focused on percent mammographic density, but there is evidence that the absolute dense area may be more relevant for breast cancer risk (7) , whilst the role of the non-dense area remains unclear (8) .
The mechanism behind this association is not known, however, several hormonal breast cancer risk factors are known to influence mammographic density (9) (10) (11) . This raises the possibility that some of the association between levels of circulating hormones and breast cancer risk may be mediated through an increase in mammographically dense area.
Circulating levels of sex hormones are thought to have an inherited component, but there have been few attempts to estimate the heritability in females. A study of postmenopausal twins estimated heritabilities of 0.14, 0.39 and 0.56 for estradiol, testosterone and SHBG levels respectively, while a study of postmenopausal women from the 6 Framlingham Heart Study found an identical heritability for SHBG but a slightly lower estimate for testosterone levels (0.26) (12, 13) Twin studies estimate that between 50% and 70% of the variance of percent mammographic density is genetically determined (14) (15) (16) (17) . A recent study used a polygenic risk score approach to demonstrate that percent mammographic density and breast cancer have a shared genetic basis that is mediated through a large number of common variants (18) . In addition, common genetic variants within the ZNF365, LSP1 and RAD51L1 genes which were initially identified as being associated with breast cancer risk have been subsequently shown to also be associated with breast density, in the direction consistent with their effect on risk (19, 20) .
Given that mammographic density and endogenous sex-hormone levels are both strong risk factors for breast cancer and may each share a common genetic basis with breast cancer, we wished to examine the association between these two traits and any evidence for a shared genetic basis.
METHODS

Study population
SIBS
The Sisters in Breast Screening study (SIBS) study was designed to study the genetic basis of quantitative phenotypes related to breast cancer, in particular breast density and sexhormone levels (21) . Women who attended the local Cambridge and Huntingdon Breast Screening Services to have mammographic examinations under the National Health Service breast screening program were identified and invited to participate in the study if they had one or more female blood relatives (sisters, half sisters, first cousins, aunts or nieces) who had also undergone mammographic screening. Women with relatives who could have screening within 7 2 years were also included. Families were also ascertained through newspaper and radio advertisements.
A letter, blood kit and questionnaire covering information on family relationships, reproductive and hormonal factors, life-style factors, oral contraceptive and hormone replacement therapy (HRT) use and medical history such as cancer and benign breast disease were sent to the participants. Twin status of participants was collected by the study coordinator and verified by comparing genome-wide genetic data. Anthropometric measurements and blood samples were taken at the general practices by trained staff (21) . 
Mammographic density estimation
Mammograms were undertaken as part of the UK National Health Service (NHS) Breast Screening Program in which women aged 50-64 years are screened every 3 years by a two-view (mediolateral and craniocaudal) mammogram. All available mammograms for each participant were retrieved from the local screening service and digitized using the Array 2905
Laser Film Digitizer and the program DICOM ScanPro Plus Version 1.3E (Array Corp), with 50-μm pixel resolution and 12-bit digitization, and an absorbance of 4.7. Density readings were performed using a computer-assisted program, CUMULUS (22) . The dense area, the non-dense area and hence the percent density (dense area expressed as a percentage of the total breast area) were estimated for each film as continuous variables. Mediolateral views of both breasts were used as they were more widely available and breast density measured by the mediolateral and craniocaudal views are known to be highly correlated. All films were assessed by a single trained reader (JB). Mammograms were analyzed in a random order. All readings were made independently for the right and the left breast. 10% of the films were rescored by the same reader for a different study and the intrareader repeatability was 0.84.
The interreader reproducibility was examined in the earlier study by comparing 10% of the readings with those of a radiologist (RW) was 0.88 (23) .
Hormone measurements
SIBS women who were more than 55 years of age, were self-reported as being postmenopausal for at least two years and not on HRT at the time of blood sampling were selected for sex hormone measurements. Serum estradiol concentrations were measured using an in-house radio-immunoassay (RIA) using a highly specific rabbit antiserum which had been raised against an estradiol-6-carboxymethyloxime-bovine serum albumin conjugate and estradiol-6-carboxymethyloxime- [2- 125 I] iodohistamine (23) . Sex-hormone binding globulin was measured using Immulite chemiluminescent immunoassay (Seimens Healthcare Diagnostic, UK) and serum testosterone levels were measured using a Coat-a-Count solid phase RIA kit from TKTT2 Seimens Healthcare Diagnostic, UK. The use of both methods has been described previously (24, 25) .
For estradiol at a concentration of 25 pmol/l the within assay variation was 6.5% and the between assay variation was 16% (n=18). For testosterone, at a concentration of 2.5nmol/l, the within assay variation was 7% and the between assay variation was 16% (n=28). For SHBG at a concentration of 50 nmol/l the within assay variation was 5.8% and the between assay variation was 6.6% (n=7).
Two women with extreme estradiol levels (>1000 pmol/l) were excluded from the estradiol analyses. 20 women (2.7%) with estradiol levels below the level of detection 9 (<3.0pmol/l) and 33 women (4.4%) with testosterone levels below detection levels (<0.14nmol/l) were assigned the value of the minimum level of detection.
Statistical Analysis
Pedigree information was available for 617 families, comprising 1286 SIBS participants and 2402 imputed relatives. The relatives were only included to provide the correct pedigree structures for the heritability estimations; no phenotype information was available for them. The 1286 SIBS women were genotyped using the Illumina HumanCytoSNP-12 platform as part of a genome-wide association study (26) . SNP assays with call rates <95% (or <99% for minor allele frequency (MAF) 1%-5%), SNPs with a MAF <1%, or Hardy-Weinberg Equilibrium P < 10 -4 were removed for a total of 255,051 genotyped SNPs. Duplicate concordance was >99.9% (n=10). All samples had a call-rate >99% and heterozygosity 30%-38%.
A subset of 8236 uncorrelated SNPs (r 2 <0.1) were used to construct a kinship coefficient matrix (GenABEL software (27) ) which was used to verify the reported relationships between the 1286 SIBS women. Where necessary, the pedigree was corrected based on the genetic data, in consultation with the study coordinator. Ten individuals from four families were excluded as having <85% estimated European ancestry and 8 individuals from 3 families were excluded where the relationships could not be clarified. After exclusions, 1268 women from 614 families with genome-wide genetic data were included in the analyses, of which 810 women had hormone data, 1140 women had breast density data and 682 women had both density and hormone measurements. closest to the time of blood sampling were taken and the mean of measures between the right and left breast readings was used (unless only one side was available, in which case the readings from that side were used). The hormone measures were log-transformed and the density measures were square-root transformed to better approximate to a normal distribution.
In the regression model each density measure (percent dense, dense area and nondense area) was taken as the outcome variable. Estradiol, testosterone and SHBG levels were the exposure variables. The final multi-variate model included age at mammogram, time between mammogram and blood sampling, ages at menarche, menopause, parity and first pregnancy, body-mass index (BMI), waist-to-hip ratio (WHR), and under bust measurements (centimetres). HRT use was categorised into 'never' and 'former' users. Analyses were done using STATA 10.0 software package (Stata Corp., College Station, TX).
Heritability estimation
Mammograms of both breasts taken at two time-points were available for most women and therefore each woman included in the heritability estimation had up to four readings of density measures. Square-root transformed density measures were adjusted for age at each mammogram. All other covariates were obtained at only one time point. The mean of residuals generated through multivariate regression was used to assign an average adjusted density value for each woman.
Stepwise linear regression was carried out to determine the best model for each of the hormones. Log-transformed estradiol levels were adjusted for age at blood draw, BMI, previous HRT use and batch. Log-transformed SHBG levels were adjusted for the above variables together with WHR. Log-transformed testosterone levels were additionally adjusted for previous HRT use, bilateral oopherectomy and age at menopause. In order to estimate the heritability of each trait, and to estimate the genetic and nongenetic correlations between pairs of traits, we use variance and co-variance components models and pedigree-based maximum likelihood methods as implemented in SOLAR (28, 29) .
Each phenotype was modeled as a linear function of the form:
where P i is the phenotype in an individual i, μ is the mean of the trait, β j the regression Once the expected mean and covariance matrix for each pedigree were defined, the likelihood of a pedigree was evaluated using the multivariate normal density function and summed over all pedigrees to obtain multiple likelihood estimates (MLE) of σ e and σ g (28) , and hence the heritability (h 
Bivariate variance components model
To evaluate evidence for common genetic effects influencing two phenotypes, for example percent density and estradiol levels, bivariate variance components models were used (30) . The phenotypic correlations between two traits were divided into the component ) calculated for the two traits, the phenotypic correlation can be expressed as the weighted sum of their genetic and environmental correlations (30);
The genetic correlations ( G ρ ) captures the extent to which the same genetic factors influence both traits, and the environmental correlations ( E ρ ) captures the extent to which the same environmental factors influence both traits. Two hypotheses were tested using likelihood ratio tests. The first hypothesis was whether the genetic correlation between the two traits was
; rejection of this hypothesis would suggest the existence of one or more genetic factors that influence both traits. The second hypothesis tested whether the environmental correlation between the two traits was zero ( 0 = E ρ ); rejection of this hypothesis would suggest that one or more unmeasured or unadjusted common environmental factors influence both traits. The statistical tests for the association between breast density and sex hormone levels were two-sided, while the tests for heritability were necessarily one-sided. 
RESULTS
The mean age at mammogram of the 1286 women included in the analyses was 61.7 years (range = 50-78years) with an average BMI of 27 kg/m 2 ( Table 1 ). The majority of women were parous (89.5 %) with an average of 2 live births. The mean percent density was 15.0 ± 11.9 %. The geometric mean levels (±standard error) of estradiol, testosterone and SHBG levels in the cohort were 14.3±2.2 pmol/l, 0.66±1.8 nmol/l and 49.4±1.6 nmol/l respectively ( Table 1) . Most of the relative pairs in the study were sisters, with cousins being the next most common relationship ( Table 2 ). None of the women included in the estimation of heritability of hormone measures were using HRT at the time of sampling. Eleven women included in the heritability estimation of density measures reported using HRT.
Square-root transformed dense area and percent density were negatively associated with age at mammogram and BMI, and positively associated with ages at first pregnancy and menarche, while the non-dense area was positively associated with age and BMI (all P < 0.05, supplementary table S1). Testosterone levels were positively associated with BMI while estradiol levels were positively associated with BMI and negatively associated with age. SHBG levels were negatively associated with BMI and positively associated with age (P<0.05, supplementary table S2).
Association between mammographic density measures and hormone measurements
Levels of estradiol and testosterone adjusted for age were negatively associated with percent density (P < 0.001 for both) and positively associated with non-dense area (P < 0.001
area (P = 0.001) and a borderline negative association was seen with testosterone levels (P = 0.03). Age adjusted SHBG levels were positively associated with percent density and negatively associated with the non-dense area of the breasts (P < 0.001 for both). After additional adjustment for BMI, none of these associations remained statistically significant, allowing for multiple testing. The inclusion of WHR, chest circumference, age at menarche and menopause, parity, HRT use (never/past users) and age at first live birth, made little difference to the results (data not shown).
Heritability estimation
After adjusting for age at mammographic examination and menopausal status, the heritability estimates for dense area, percent density and the non-dense area of the breasts were 68%, 70% and 77% respectively (Table 4) . On further adjustment for BMI, WHR, HRT use, age at menarche and age at menopause, the heritability estimates reduced to 66%, 63% and 65% for the three measures respectively.
Heritability estimates for hormone levels adjusted for age at blood draw and batch were 52%, 59% and 27% for estradiol, SHBG and testosterone levels respectively. On further adjustment for BMI, WHR, HRT use, bilateral oophorectomy and age at menopause, the heritability estimates were 40%, 58% and 25% respectively (Table 4) .
Genetic and environmental correlations between density measures and circulating sexhormone levels
Estimates of genetic (ρ G ) and environmental (ρ E ) correlations between each density measure and each sex-hormone level are given in menopausal status, non-dense area was positively genetically correlated with age adjusted testosterone levels (P-value = 0.001 for test of ρ G = 0). This positive association was seen to drive the negative genetic association between percent density and testosterone levels (as the non-dense area forms part of the denominator of percent density). The results were similar for estradiol levels. The non-dense area and SHBG levels were negatively genetically correlated with each other, while percent density and SHBG levels were positively genetically correlated (P-value = 0.03 for test of ρ G = 0 for both traits) ( Table 5 ).
After multi-variate adjustment for BMI, WHR and other risk factors, there was no significant evidence of shared genetic influences between hormone and density measures (H 0 : ρ G = 0), with the exception of a borderline association between non-dense area and testosterone (P=0.04). There was no evidence of shared environmental factors in any of the analyses (H 0 : ρ E = 0) ( Table 5 ).
Genetic and environmental correlations among density measures, sex-hormone levels and body-mass index
To explore this further we tested for genetic and/or environmental sharing between BMI and each trait of interest, adjusting for age and menopausal status. The results provide strong evidence of common genetic factors influencing the non-dense area and BMI in the same direction (P=6.6x10 -14 ), and hence affecting percent density and BMI in opposite directions (P=5.2x10 -7 ). There was, however, no evidence of a shared genetic component to BMI and dense area. Estradiol was positively genetically correlated with BMI, while SHBG levels showed inverse genetic correlation; testosterone was not genetically correlated with BMI ( Table 6 ).
The dense and non-dense areas of breasts adjusted for age at mammogram and menopausal status showed significant negative genetic correlations (P = 8.0x10 -5 ) (Table 7) 
DISCUSSION
Mammographic density is known to respond to changes in a woman's hormonal milieu. It has been hypothesized that some of the increased risk of breast cancer caused by endogenous hormones through cell proliferation may be reflected as a change in mammographic density (5).
In our cross-sectional study of 682 post-menopausal women, we found no strong associations between estradiol, testosterone and SHBG levels and any of the three density measures, after adjusting for adiposity (BMI), in line with most, but not all, of the previous studies in this area (31) (32) (33) (34) (35) (36) (37) (38) . The majority of the previous studies were relatively small in size (n<300) and/or considered only percent density, rather than also looking at the absolute dense and non-dense areas. A study of 722 postmenopausal Norwegian women found significant positive correlations between SHBG levels and both percent and absolute density even after adjusting for BMI (39), but may not have completely corrected for adiposity. Our results support those from the Nurses Health Study which found circulating levels of estradiol and testosterone to be strongly associated with breast cancer risk independent of percent mammographic density, and vice versa (40) . This absence of association is perhaps surprising given the known association between HRT use and density. It may be that the levels of endogenous sex-hormones in postmenopausal women are too low to cause a detectable effect on mammographic density, or that the variability in the levels and/or densities are too small to provide sufficient statistical power. It is known that there is a much stronger relationship between combined estrogen and progesterone HRT and breast density than there is with just estrogen-HRT and breast density (41) (42) (43) . The very low progesterone levels in postmenopausal women may be why these analyses found little relationship between estradiol levels and mammographic density. The mean age at mammogram in our study was 61.7 years, thus we can not rule out the possibility that significant associations may be evident in a cohort of younger women. Indeed, it may be that mammographic density is determined more by longerterm hormonal exposure and is less affected by variations in postmenopausal hormones.
All six variables appear to have substantial inherited components; the estimated heritabilities were 63%, 66% and 65% for square-root transformed adjusted percentdensity, dense area and non-dense area respectively, and 40%, 25% and 58% for logtransformed adjusted estradiol, testosterone and SHBG. It is interesting to note that the density heritabilities are almost identical to those from a large North American/Australian twin-study, despite the different study designs and the different statistical methodologies used (14, 15) . Our estimated heritabilites are a little lower than those from a Korean study of twins and first degree relatives (16) but higher than those from a Californian twin study, especially for non-dense area (31%) (17) . However, the results from a sibling study among women belonging to the Old Amish population in Pennsylvania (30) were somewhat different, with heritability estimates of 35% for log percent density, 39% for log dense area and 71% for 0.3-power transformed non-dense area.
Our estimated heritability for log SHBG levels was very similar to those estimated in a twin study from Australia (0.56) (13) and in families from the Framingham Heart Study (also 0.56) (12) . Our heritability for log testosterone was similar to the Framingham study (0.25) but a little lower than the twin study estimate (0.39 for squareroot transformed testosterone), while our heritability for log estradiol levels (0.40) was somewhat higher than in the twin study (0.14). 
Heritability estimates are population specific, as variations in additive and nonadditive genetic variances as well as environmental variances can be vary between populations (44). For example, the specific reproductive norms within the Amish population meant that parity was higher than in most Western populations which could affect the total variance of density measures such that the proportion of variance explained by additive genetic factors may be lower (30) . In our study, healthy women recruited through a population-based screening program give heritability estimates that are more generalizable to a Western population. This is the first study to look for a shared genetic basis between breast density and sex hormone levels. The apparent genetic associations for testosterone and SHBG levels with non-dense area (and hence percent density) were attenuated and became nonsignificant after adjusting for BMI. The role of BMI as a confounder was confirmed by identifying a positive genetic correlation between BMI and non-dense area (and hence a negative correlation with percent density) and genetic correlations between BMI and estradiol (positive) and SHBG (negative). However, we did identify a significant negative genetic correlation between dense and non-dense areas, which remained significant even after adjustment for BMI and other covariates (ρ=-0.34, P=0.0005). This correlation is close to the estimates reported by Stone et al (15) and Sung et al (16) in their twin studies (ρ =-0.30, and ρ =-0.25 respectively), pointing to the existence of genetic loci with opposing effects on dense and non-dense tissue. We did not find any such correlation between the non-genetic determinants of the two traits (P=0.13), making it unlikely that the observed genetic correlation is an artifact of the way dense and nondense areas are measured. A unique strength of this study is the ability to verify family relations reported in questionnaires using kinship coefficients calculated using genome-wide SNP data. This led to several corrections and exclusions of individuals from the study. Correlations among parents and siblings can be affected by common environmental influences which could lead to heritability estimates being overestimated (13) . The inclusion of more distant relatives may help, as their correlations are less likely to be biased by non-genetic factors, however, heritability estimates based on distant relatives alone would have high sampling errors. Families with extended pedigrees were included in the present study using a statistical method that was designed to use information from such a structure (28) . 
CONCLUSIONS
In this population-based study of families with extended pedigrees, high heritability estimates obtained from twin studies for density measures were confirmed.
Dense and the non-dense areas of the breasts were shown to be influenced partly by the same genetic factors but in opposite directions, while BMI and the non dense breast area were positively genetically correlated. High heritability estimates were also found for estradiol and SHBG. After adjustment for BMI, there was no evidence for a shared genetic basis between the density measures and sex-hormones included in this study, hence the established relationships between endogenous sex hormone levels and breast cancer risk do not appear to be explained by variations in breast density in this age group.
Breast density and sex hormones can thus be considered as independent sets of traits, each of which can be used as intermediate phenotypes in the search for breast cancer susceptibility loci. Values significant with a P-value less than 0.05 have been highlighted *Density measures were square-root transformed and adjusted for age, previous HRT use, BMI, WHR, age at first birth, menarche and menopause. ** Estradiol levels were log-transformed and adjusted for age at blood draw, BMI, HRT use and batch § § SHBG levels were log-transformed and adjusted for age at blood draw, BMI, WHR, HRT use and batch ↨↨ Testosterone levels were log-transformed and adjusted for age at blood draw, BMI, HRT use, bilateral oopherectomy, age at menopause and batch ↑ P-value for test of null hypothesis that correlation due to additive genetic factors is zero(ρ G=0 ) § Phenotypic correlation estimate ↑↑ The sample size for estradiol levels and density measures correlation estimation was 1284. 
